| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 11030657 | Atherosclerosis | 2018 | 6 Pages | 
Abstract
												These results imply that only a small proportion of FH patients achieved the recommended LDL-Ch treatment targets, mostly due to the use of low statin dose and infrequent implementation of high-intensity statin treatment, which altogether could not prevent the increase in residual cardiovascular risk.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Katarina LaliÄ, NataÅ¡a RajkoviÄ, Ljiljana PopoviÄ, Sandra Singh LukaÄ, Ljubica StoÅ¡iÄ, Iva RasuliÄ, NebojÅ¡a M. LaliÄ, 
											